Results 201 to 210 of about 3,377,134 (229)

The effect of glucagon-like peptide-1 and glucose dependent insulinotropic polypeptide receptor agonists on neurogenesis, differentiation, and plasticity (Neuro-GDP): potential mechanistically informed therapeutics in the treatment and prevention of mental disorders. [PDF]

CNS Spectr
McIntyre RS, Rasgon N, Goldberg J, Wong S, Le GH, Mansur RB, Rosenblat JD, Teopiz KM, Stahl SM.   +8 more
europepmc   +1 more source

Glucose-Dependent Insulinotropic Polypeptide Inhibits AGE-Induced NADPH Oxidase-Derived Oxidative Stress Generation and Foam Cell Formation in Macrophages Partly via AMPK Activation. [PDF]

Int J Mol Sci
Terasaki M, Yashima H, Mori Y, Saito T, Inoue N, Matsui T, Osaka N, Fujikawa T, Ohara M, Yamagishi SI.   +9 more
europepmc   +1 more source

Skeletal Muscle Mass and Body Weight Fall Proportionally With Use of Dual Glucagon-Like Peptide 1/Glucose-Dependent Insulinotropic Polypeptide Receptor Agonist Tirzepatide: Case Report and Review of Literature. [PDF]

AACE Clin Case Rep
Zinn J, Poretsky L.
europepmc   +1 more source

The Road towards Triple Agonists: Glucagon-Like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide and Glucagon Receptor - An Update. [PDF]

Endocrinol Metab (Seoul)
Jakubowska A, Roux CWL, Viljoen A.
europepmc   +1 more source

The association between glucose-dependent insulinotropic polypeptide and/or glucagon-like peptide-1 receptor agonist prescriptions and substance-related outcomes in patients with opioid and alcohol use disorders: A real-world data analysis. [PDF]

Addiction
Qeadan F, McCunn A, Tingey B.
europepmc   +1 more source

A Case Report of Systemic Allergic Reaction to the Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonist Tirzepatide. [PDF]

Cureus
Le TTB, Minh LHN, Devi P, Islam N, Sachmechi I.   +4 more
europepmc   +1 more source

Evaluating glucose-dependent insulinotropic polypeptide and glucagon as key regulators of insulin secretion in the pancreatic islet.

Am J Physiol Endocrinol Metab
Lewandowski SL, El K, Campbell JE.
europepmc   +1 more source

Effect of Dual Glucagon-Like Peptide 1/Glucose-Dependent Insulinotropic Polypeptide Receptor Agonist (Tirzepatide) versus Bariatric Surgery on Weight Loss and Nonalcoholic Fatty Liver Disease. [PDF]

Med Princ Pract
Al-Sabah S, Al-Khairi I, Jamal M, Jamal M, Qaddoumi M, Alajmi F, Kumar J, Abukhalaf N, Cherian P, Madhu D, Arefanian H, Dsouza C, Alam-Eldin N, AlSabagh A, Al Madhoun A, Al-Sabah S, Al-Mulla F, Abu-Farha M, Abubaker J.   +18 more
europepmc   +1 more source